189 related articles for article (PubMed ID: 24446483)
1. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function.
Jean C; Chen XL; Nam JO; Tancioni I; Uryu S; Lawson C; Ward KK; Walsh CT; Miller NL; Ghassemian M; Turowski P; Dejana E; Weis S; Cheresh DA; Schlaepfer DD
J Cell Biol; 2014 Jan; 204(2):247-63. PubMed ID: 24446483
[TBL] [Abstract][Full Text] [Related]
2. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development.
Zhao X; Peng X; Sun S; Park AY; Guan JL
J Cell Biol; 2010 Jun; 189(6):955-65. PubMed ID: 20530207
[TBL] [Abstract][Full Text] [Related]
3. Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice.
Alexopoulou AN; Lees DM; Bodrug N; Lechertier T; Fernandez I; D'Amico G; Dukinfield M; Batista S; Tavora B; Serrels B; Hodivala-Dilke K
J Pathol; 2017 Jul; 242(3):358-370. PubMed ID: 28444899
[TBL] [Abstract][Full Text] [Related]
4. Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861.
Pedrosa AR; Bodrug N; Gomez-Escudero J; Carter EP; Reynolds LE; Georgiou PN; Fernandez I; Lees DM; Kostourou V; Alexopoulou AN; Batista S; Tavora B; Serrels B; Parsons M; Iskratsch T; Hodivala-Dilke KM
Cancer Res; 2019 Sep; 79(17):4371-4386. PubMed ID: 31189647
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration.
Turowski P; Martinelli R; Crawford R; Wateridge D; Papageorgiou AP; Lampugnani MG; Gamp AC; Vestweber D; Adamson P; Dejana E; Greenwood J
J Cell Sci; 2008 Jan; 121(Pt 1):29-37. PubMed ID: 18096689
[TBL] [Abstract][Full Text] [Related]
6. Endothelial FAK is required for tumour angiogenesis.
Tavora B; Batista S; Reynolds LE; Jadeja S; Robinson S; Kostourou V; Hart I; Fruttiger M; Parsons M; Hodivala-Dilke KM
EMBO Mol Med; 2010 Dec; 2(12):516-28. PubMed ID: 21154724
[TBL] [Abstract][Full Text] [Related]
7. ERG activity is regulated by endothelial FAK coupling with TRIM25/USP9x in vascular patterning.
D'Amico G; Fernandez I; Gómez-Escudero J; Kim H; Maniati E; Azman MS; Mardakheh FK; Serrels B; Serrels A; Parsons M; Squire A; Birdsey GM; Randi AM; Bolado-Carrancio A; Gangeswaran R; Reynolds LE; Bodrug N; Wang Y; Wang J; Meier P; Hodivala-Dilke KM
Development; 2022 Jul; 149(13):. PubMed ID: 35723257
[TBL] [Abstract][Full Text] [Related]
8. FAK regulates tension transmission to the nucleus and endothelial transcriptome independent of kinase activity.
Akhter MZ; Yazbeck P; Tauseef M; Anwar M; Hossen F; Datta S; Vellingiri V; Chandra Joshi J; Toth PT; Srivastava N; Lenzini S; Zhou G; Lee J; Jain MK; Shin JW; Mehta D
Cell Rep; 2024 May; 43(6):114297. PubMed ID: 38824643
[TBL] [Abstract][Full Text] [Related]
9. The predictive power of the desmo-adhesome.
Cirillo N; Prime SS
Cell Mol Life Sci; 2016 Feb; 73(3):685-6. PubMed ID: 26703436
[No Abstract] [Full Text] [Related]
10. To Fuse or Not to Fuse.
Simpson LJ; Tzima E
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1959-1960. PubMed ID: 30354263
[No Abstract] [Full Text] [Related]
11. FAK in cancer: mechanistic findings and clinical applications.
Sulzmaier FJ; Jean C; Schlaepfer DD
Nat Rev Cancer; 2014 Sep; 14(9):598-610. PubMed ID: 25098269
[TBL] [Abstract][Full Text] [Related]
12. An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.
Seguin L; Kato S; Franovic A; Camargo MF; Lesperance J; Elliott KC; Yebra M; Mielgo A; Lowy AM; Husain H; Cascone T; Diao L; Wang J; Wistuba II; Heymach JV; Lippman SM; Desgrosellier JS; Anand S; Weis SM; Cheresh DA
Nat Cell Biol; 2014 May; 16(5):457-68. PubMed ID: 24747441
[TBL] [Abstract][Full Text] [Related]
13. Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland.
Desgrosellier JS; Lesperance J; Seguin L; Gozo M; Kato S; Franovic A; Yebra M; Shattil SJ; Cheresh DA
Dev Cell; 2014 Aug; 30(3):295-308. PubMed ID: 25117682
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Achilles' heel of drug-resistant cancer stem cells.
Seguin L; Gozo M; Weis SM; Cheresh DA
Cell Cycle; 2014; 13(13):2017-8. PubMed ID: 24906000
[No Abstract] [Full Text] [Related]
15. Variety in the tumor microenvironment: integrin splicing regulates stemness.
Seguin L; Weis SM; Cheresh DA
Cell Stem Cell; 2014 May; 14(5):557-8. PubMed ID: 24792112
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.
Roy-Luzarraga M; Hodivala-Dilke K
Clin Cancer Res; 2016 Aug; 22(15):3718-24. PubMed ID: 27262114
[TBL] [Abstract][Full Text] [Related]
17. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Jiang H; Hegde S; Knolhoff BL; Zhu Y; Herndon JM; Meyer MA; Nywening TM; Hawkins WG; Shapiro IM; Weaver DT; Pachter JA; Wang-Gillam A; DeNardo DG
Nat Med; 2016 Aug; 22(8):851-60. PubMed ID: 27376576
[TBL] [Abstract][Full Text] [Related]
18. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective.
Abdulnour RE; Dalli J; Colby JK; Krishnamoorthy N; Timmons JY; Tan SH; Colas RA; Petasis NA; Serhan CN; Levy BD
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16526-31. PubMed ID: 25369934
[TBL] [Abstract][Full Text] [Related]
19. Differential apicobasal VEGF signaling at vascular blood-neural barriers.
Hudson N; Powner MB; Sarker MH; Burgoyne T; Campbell M; Ockrim ZK; Martinelli R; Futter CE; Grant MB; Fraser PA; Shima DT; Greenwood J; Turowski P
Dev Cell; 2014 Sep; 30(5):541-52. PubMed ID: 25175707
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
